Magnetic resonance imaging for patients with cardiomyopathy: a review of the clinical-effectiveness
Pohar R, Argaez C
Record ID 32011001280
English
Authors' recommendations:
A limited number of small, observational studies were identified in which 2-D echocardiography or angiography was compared to CMRI in the diagnosis of cardiomyopathy. CMRI and 2-D echocardiography were compared in three studies in patient with HCM. These studies demonstrated that similar measurements could be obtained with both techniques. The clinical importance of small differences in the measurements obtained is not clear from these studies. Thus, from a diagnostic perspective, CMRI may have some advantages in HCM. CMRI may also have an advantage over echocardiography in detecting thrombi in patients with dilated or ischemic cardiomyopathies. Policy decisions about the use of CMRI in cardiomyopathy are likely best made for each cardiomyopathy and according to indication (i.e., diagnosis or evaluation). There appears to be insufficient evidence available at this time to support such decisions.
Details
Project Status:
Completed
Year Published:
2009
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Magnetic Resonance Imaging
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.